Northwest Biotherapeutics (NWBO) Goodwill & Intangibles (2020 - 2026)

Northwest Biotherapeutics' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $52.7 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles rose 2646.3% year-over-year to $52.7 million in Q1 2026; TTM through Mar 2026 was $52.7 million, a 2646.3% increase from a year earlier, with the FY2025 full-year figure at $53.8 million, up 2705.74% from the prior year.
• Goodwill & Intangibles slipped to $52.7 million in Q1 2026 per NWBO's latest filing, from $53.8 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $53.8 million in Q4 2025 and bottomed at $1.9 million in Q1 2022.
• The 5-year median for Goodwill & Intangibles is $1.9 million (2022), against an average of $8.0 million.
• Across the five-year window, Goodwill & Intangibles changed 0.0% in 2022 and jumped 2705.74% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $1.9 million in 2022, then changed by 0.0% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then soared by 2705.74% to $53.8 million in 2025, then declined by 2.12% to $52.7 million in 2026.
• Per Business Quant, the three latest NWBO Goodwill & Intangibles figures stand at $52.7 million (Q1 2026), $53.8 million (Q4 2025), and $1.9 million (Q3 2025).